UroGen submits FDA application for bladder cancer drug UGN-103
UroGen Pharma Ltd. submitted a request to the US FDA to approve a new medicine for bladder cancer. The medicine is called UGN-103. It is for people with a type of bladder cancer that is not very serious but can come back.
5.6Significance
1 source5.0Source trust